Literature DB >> 12423509

A phased consent policy for cord blood donation.

Dorothy E Vawter1, Gayl Rogers-Chrysler, Mary Clay, Larrie Pittelko, Dave Therkelsen, Debora Kim, Jeffrey McCullough.   

Abstract

This article focuses on ethical and policy questions concerning when consent may be sought for the collection and donation of cord blood. It reviews the advantages and disadvantages of alternative times for securing consent, challenges common objections to seeking consent during labor or after collection, and describes a phased consent process--a process that permits consent during early labor to the ex utero collection of cord blood followed by after-consent collection to donation. The phased consent policy attends to the unique characteristics of cord blood collection and donation, respects donors and their families, maximizes the number and diversity of cord blood units collected, preserves the relationship between providers and patients, and preserves public trust in cord blood and other types of tissue banking.

Entities:  

Keywords:  Health Care and Public Health; Professional Patient Relationship

Mesh:

Year:  2002        PMID: 12423509     DOI: 10.1046/j.1537-2995.2002.00227.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

Review 1.  Untying the Gordian knot: policies, practices, and ethical issues related to banking of umbilical cord blood.

Authors:  Joanne Kurtzberg; Anne Drapkin Lyerly; Jeremy Sugarman
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

2.  US public cord blood banking practices: recruitment, donation, and the timing of consent.

Authors:  Sherri M Broder; Roselle S Ponsaran; Aaron J Goldenberg
Journal:  Transfusion       Date:  2012-07-15       Impact factor: 3.157

3.  The acceptability to women in Mombasa, Kenya, of the donation and transfusion of umbilical cord blood for severe anaemia in young children.

Authors:  O Hassall; L Ngina; W Kongo; J Othigo; K Mandaliya; K Maitland; I Bates
Journal:  Vox Sang       Date:  2007-12-14       Impact factor: 2.144

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.